WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (NYSE MKT: NNVC) (the “Company”) reported today that it has designed and synthesized novel nanoviricides® drug candidates in quantities sufficient for testing in animals infected with the MERS Corona Virus.
Help employers find you! Check out all the jobs and post your resume.
